New study tracks how risankizumab eases ulcerative colitis in daily practice

NCT ID NCT07136116

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This study follows about 200 adults in Japan with moderate to severe ulcerative colitis who are prescribed risankizumab by their doctors as part of routine care. Researchers will track changes in disease activity, like stool frequency and rectal bleeding, for up to 156 weeks. The goal is to see how well the drug works in real-world settings, not just in controlled trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aichi Medical University Hospital /ID# 278155
RECRUITING

Nagakute, Aichi-ken, 480-1195, Japan
Chiba University Hospital /ID# 277669
RECRUITING

Chiba, Chiba, 260-8677, Japan
Dokkyo Medical University Hospital /ID# 278152
RECRUITING

Mibu, Tochigi, 321-0293, Japan
Fukuoka University Hospital /ID# 277677
RECRUITING

Fukuoka, 814-0180, Japan
Hamamatsu University Hospital /ID# 277539
RECRUITING

Hamamatsu, Shizuoka, 431-3192, Japan
Hirosaki University Hospital /ID# 278153
RECRUITING

Hirosaki, Aomori, 036-8563, Japan
Hiroshima University Hospital /ID# 277542
NOT_YET_RECRUITING

Hiroshima, 734-8551, Japan
Hokkaido University Hospital /ID# 277668
RECRUITING

Sapporo, Hokkaido, 060-8648, Japan
Hyogo Medical University Hospital /ID# 277676
RECRUITING

Nishinomiya-shi, Hyōgo, 663-8501, Japan
Institute of Science Tokyo Hospital /ID# 277538
RECRUITING

Bunkyo-ku, Tokyo, 113-8519, Japan
Kansai Medical University Hospital /ID# 278619
RECRUITING

Hirakata-shi, Osaka, 573-1191, Japan
Kitasato University Kitasato Institute Hospital /ID# 278154
RECRUITING

Minato-ku, Tokyo, 108-8642, Japan
Kobe University Hospital /ID# 278292
RECRUITING

Kobe, Hyōgo, 650-0017, Japan
Kyorin University Hospital /ID# 277534
RECRUITING

Mitaka-shi, Tokyo, 181-8611, Japan
Kyushu University Hospital /ID# 278077
RECRUITING

Fukuoka, Fukuoka, 812-8582, Japan
NHO Shizuoka Medical Center /ID# 278075
RECRUITING

Sunto-gun, Shizuoka, 411-8611, Japan
Nagoya University Hospital /ID# 278159
RECRUITING

Nagoya, Aichi-ken, 466-8560, Japan
Saga University Hospital /ID# 278160
RECRUITING

Saga, Saga-ken, 849-8501, Japan
Saitama Medical Center /ID# 278076
RECRUITING

Kawagoe, Saitama, 350-8550, Japan
Sapporo Higashi Tokushukai Hospital /ID# 278123
RECRUITING

Sapporo, Hokkaido, 065-0033, Japan
Sapporo Kosei General Hospital /ID# 278048
RECRUITING

Sapporo, 060-0033, Japan
Sapporo Medical University Hospital /ID# 277535
RECRUITING

Sapporo, Hokkaido, 060-8543, Japan
Shiga University of Medical Science Hospital /ID# 277540
RECRUITING

Ōtsu, Shiga, 520-2192, Japan
The Jikei University Hospital /ID# 278122
RECRUITING

Tokyo, 105-8461, Japan
Toho University Sakura Medical Center /ID# 277536
RECRUITING

Sakura, Chiba, 285-0841, Japan
Toyama University Hospital /ID# 277675
RECRUITING

Toyama, 930-0194, Japan
Tsujinaka Hospital - Kashiwanoha /ID# 277672
RECRUITING

Kashiwa-shi, Chiba, 277-0871, Japan
University Hospital Kyoto Prefectural University of Medicine /ID# 277541
RECRUITING

Kyoto, Kyoto, 602-8566, Japan

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS ULCERATIVE COLITIS